Published in Mol Hum Reprod on June 01, 1998
Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci (2008) 1.24
Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma. Fertil Steril (2007) 0.85
Divergent regulation of angiopoietin-1 and -2, Tie-2, and thrombospondin-1 expression by estrogen in the baboon endometrium. Mol Reprod Dev (2010) 0.76
Methotrexate for prophylaxis of choriocarcinoma. Am J Obstet Gynecol (1971) 2.22
Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci U S A (1992) 1.95
Baboon corpus luteum: the effect of melatonin on in vitro progesterone production. Fertil Steril (1993) 1.39
New concepts in dysmenorrhea. Am J Obstet Gynecol (1978) 1.36
Subunit composition and specificity of the major cyst fluid antigens of Echinococcus granulosus. Mol Biochem Parasitol (1989) 1.35
Comparison of diagnostic accuracy of laparoscopy, hysteroscopy, and hysterosalpingography in evaluation of female infertility. Fertil Steril (1984) 1.30
Dysmenorrhea. J Reprod Med (1985) 1.29
Retention of intrauterine fetal bone increases menstrual prostaglandins. Obstet Gynecol (1990) 1.23
Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J Immunol (1985) 1.13
Human seminal clusterin (SP-40,40). Isolation and characterization. J Clin Invest (1990) 1.12
Observations on choriocarcinoma in Singapore. Obstet Gynecol (1972) 1.12
Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab (1979) 1.10
Prolonged intrauterine retention of fetal bones after abortion causing infertility. Am J Obstet Gynecol (1982) 1.08
Early malignant disease of the chorion. Acta Obstet Gynecol Scand (1971) 1.08
cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol (1992) 1.06
Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. J Pharmacokinet Biopharm (1992) 1.01
Ibuprofen and dysmenorrhea. Am J Med (1984) 0.99
Oxytocin in human pregnancy and parturition. Obstet Gynecol (1978) 0.99
Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis. Lymphokine Cytokine Res (1992) 0.99
Oxytocin release and plasma anterior pituitary and gonadal hormones in women during lactation. J Clin Endocrinol Metab (1981) 0.98
Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest (2004) 0.98
ABO blood group in trophoblastic disease. J Obstet Gynaecol Br Commonw (1971) 0.98
Testosterone and dihydrotestosterone in maternal and cord blood and in amniotic fluid. Am J Obstet Gynecol (1977) 0.98
Epidemiology of hydatidiform mole in Singapore. Am J Obstet Gynecol (1971) 0.98
Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output. Hum Reprod (2009) 0.97
Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol (1998) 0.93
Inhibition of the mitogen activated protein kinase, p38 alpha, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading. Atherosclerosis (2001) 0.93
Automated semen analysis: 'zona pellucida preferred' sperm morphometry and straight-line velocity are related to pregnancy rate in subfertile couples. Hum Reprod (2003) 0.92
Ruptured haemangioma of a gravid uterus. J Obstet Gynaecol Br Commonw (1972) 0.92
Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women. Am J Med (1980) 0.91
Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am J Med (1981) 0.91
Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril (2000) 0.91
Triplet pregnancy. Aust N Z J Obstet Gynaecol (1973) 0.91
Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma. Obstet Gynecol (1977) 0.91
Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values. Bioorg Med Chem (2001) 0.90
Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion. Pharm Res (1997) 0.90
Mononuclear phagocyte activation: activation-associated antigens. Fed Proc (1986) 0.89
Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol (1979) 0.89
Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Drugs (1981) 0.88
Plasma levels of oxytocin and 13, 14-dihydro-15-keto prostaglandin F2 alpha in preterm labor and the effect of ethanol and ritodrine. Am J Obstet Gynecol (1982) 0.88
Progesterone and estradiol in the saliva and plasma during the menstrual cycle. Am J Obstet Gynecol (1983) 0.87
Induction of labor with pulsatile oxytocin. Am J Obstet Gynecol (1990) 0.87
Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostaglandin Thromboxane Res (1980) 0.87
Quality of life during sequential hormone replacement therapy -- a placebo-controlled study. Int J Fertil Menopausal Stud (1995) 0.87
Novel anti-inflammatory compounds induce shedding of L-selectin and block primary capture of neutrophils under flow conditions. J Immunol (1997) 0.87
Hormonal profile as a prognostic index of early threatened abortion. Am J Obstet Gynecol (1978) 0.87
Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet Gynecol (1997) 0.86
Unilateral tubo-ovarian abscess and intrauterine contraceptive devices. Obstet Gynecol (1975) 0.86
Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles. Am J Obstet Gynecol (1976) 0.85
Comparison of Percoll, mini-Percoll and swim-up methods for sperm preparation from abnormal semen samples. Hum Reprod (1992) 0.84
Studies of oxytocin in the baboon during pregnancy and delivery. Acta Endocrinol (Copenh) (1979) 0.84
Sperm preparation for intracytoplasmic injection: methods and relationship to fertilization results. Reprod Fertil Dev (1995) 0.83
Interleukin-1 beta induces cyclooxygenase-2 gene expression in cultured endometrial stromal cells. J Clin Endocrinol Metab (1998) 0.83
Fetal contribution to oxytocin in human labor. Obstet Gynecol (1978) 0.83
Clinical and histologic evaluation of laser reanastomosis of the uterine tube. Fertil Steril (1984) 0.82
Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am J Obstet Gynecol (1984) 0.82
Oxytocin release and uterine activation during parturition iin rabbits. Endocrinology (1980) 0.82
Epidermal growth factor receptors in uteroplacental tissues in term pregnancy before and after the onset of labor. J Clin Endocrinol Metab (1997) 0.82
A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor. J Immunol (1986) 0.82
Salivary and plasma bound and "free" testosterone in men and women. Am J Obstet Gynecol (1984) 0.82
Hormones and cervical ripening: dehydroepiandrosterone sulfate, estradiol, estriol, and progesterone. Am J Obstet Gynecol (1986) 0.81
Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values. J Med Chem (1999) 0.81
Systemic lupus erythematosus in men. Genetic and endocrine features. Arch Intern Med (1982) 0.81
Assessment of the Sperm Quality Analyzer. Fertil Steril (1995) 0.81
Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am J Obstet Gynecol (1984) 0.81
Epidermal growth factor and basic fibroblast growth factor in peritoneal fluid of women with endometriosis. Fertil Steril (1996) 0.81
Granulosa and theca cell tumors. Obstet Gynecol (1978) 0.81
Glycolipid affinity purification of migration inhibitory factor. Nature (1982) 0.81
Alterations in reproductive tissue prostaglandins E and F, 6-keto-prostaglandin F1 alpha and thromboxane B2 with gestational age in the rat. Biol Reprod (1982) 0.80
Marital sex frequency and midcycle female testosterone. Arch Sex Behav (1987) 0.80
Hormones in amniotic fluid. Am J Obstet Gynecol (1977) 0.80
Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation. Infect Immun (1980) 0.80
Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma. Am J Obstet Gynecol (1975) 0.80
Role of sialic acid in the macrophage glycolipid receptor for MIF. J Immunol (1980) 0.80
Serum estradiol-17beta and serum human chorionic gonadotropin in patients with hydatidiform moles. Am J Obstet Gynecol (1974) 0.80
The use of anticlusterin monoclonal antibodies for the combined assessment of human sperm morphology and acrosome integrity. Hum Reprod (1994) 0.80
Radioimmunoassay of oxytocin. J Endocrinol (1978) 0.80
Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles. Am J Obstet Gynecol (1974) 0.79
Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives. Am J Obstet Gynecol (1986) 0.79
Oxytocin content of human fetal pituitary glands. Am J Obstet Gynecol (1984) 0.79
Human mononuclear phagocyte activation antigens. Blood Cells (1990) 0.79
Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma. Acta Endocrinol (Copenh) (1972) 0.79
Baboon corpus luteum oxytocin: an intragonadal peptide modulator of luteal function. Am J Obstet Gynecol (1988) 0.79
Oxytocin levels and disappearance rate and plasma follicle-stimulating hormone and luteinizing hormone after oxytocin infusion in men. J Clin Endocrinol Metab (1980) 0.79
Diagnosis of sperm defects in selecting patients for assisted fertilization. Hum Reprod (1993) 0.78
Purification, biochemical composition, and biosynthesis of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J Immunol (1991) 0.78
Evidence for an intracellular pool of a migration inhibitory factor-associated, activation antigen of human mononuclear phagocytes, Mo3e. J Immunol (1988) 0.78
Human ovaries contain immunoreactive oxytocin. J Clin Endocrinol Metab (1983) 0.78
Seminal plasma proteins of fertile and infertile men analyzed by two-dimensional electrophoresis. Am J Obstet Gynecol (1987) 0.78
Chorionic gonadotropin receptors and immunoreactive chorionic gonadotropin in implantation of the rabbit blastocyst. Am J Obstet Gynecol (1984) 0.78
Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metab (1989) 0.78
Human ovarian oxytocin: its source and relationship to steroid hormones. Am J Obstet Gynecol (1986) 0.78
Expression of the human relaxin gene in the corpus luteum of the menstrual cycle and in the prostate. Mol Cell Endocrinol (1989) 0.78
Expression of gap junction protein connexin-43 in the human and baboon (Papio anubis) corpus luteum. J Clin Endocrinol Metab (1996) 0.78
Circulating maternal serum progesterone in high-risk pregnancies. Am J Obstet Gynecol (1976) 0.78
Isolation of a guinea pig macrophage glycolipid with the properties of the putative migration inhibitory factor receptor. J Biol Chem (1982) 0.78
Human umbilical arterial and venous progesterone concentrations: effect of fetal sex, weight, and mode of delivery. Obstet Gynecol (1977) 0.78
Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential. J Pharm Pharmacol (1999) 0.78
Hormonal regulation of connexin-43 in baboon corpora lutea. J Endocrinol (1998) 0.78